Heelan J S, Chesney D, Guadagno G
Department of Pathology, Memorial Hospital of Rhode Island, Pawtucket 02860.
J Clin Microbiol. 1992 Jul;30(7):1674-7. doi: 10.1128/jcm.30.7.1674-1677.1992.
It was noted in our laboratory that certain strains of Haemophilus influenzae yielded zone sizes interpreted as resistant to the ampicillin (AMP) disk on chocolate-Mueller-Hinton agar (CMH) but showed no evidence of beta-lactamase (beta-Lac) activity. Although it is known that a second mechanism of AMP resistance exists, strains with this mechanism are uncommon. To investigate this apparent discrepancy, a study of 100 consecutive clinical isolates of H. influenzae collected over a 6-month period was performed. Isolates were simultaneously tested against five antibiotics (AMP, chloramphenicol, cefotaxime, ciprofloxacin, and AMP-sulbactam) on CMH and on two brands of Haemophilus test medium (HTM) by using the disk diffusion procedure and National Committee for Clinical Laboratory Standards (NCCLS) standards. By using CMH and NCCLS standard M2-A3-S2, strains of H. influenzae showing zone sizes of greater than or equal to 20 mm with AMP were considered sensitive. By using HTM and NCCLS standard M2-A4, strains showing zone sizes of greater than or equal to 25 mm to AMP on HTM were considered sensitive. Intermediate strains had zone sizes of 22 to 24 mm. The majority of isolates (68%) were sensitive to all antibiotics. Two percent of the isolates were resistant to chloramphenicol. Seventeen percent of the isolates were AMP-resistant, beta-Lac-producing strains of H. influenzae. Thirteen percent of the isolates gave at least one intermediate or resistant zone for AMP but were beta-Lac negative. MIC determinations with NCCLS standard M7-A2 were performed with resistant and intermediate strains. MICs for beta-Lac-producing strains of H. influenzae were >/= 8.0 microgram/ml. MICs for beta-Lac-negative strains were </= 1.0 microgram/ml and were highly reproducible. If one uses the current NCCLS zone diameter interpretive criteria, results should be viewed with caution. Further investigation of zone size interpretive criteria is warranted. It is suggested that in the case of serious infections with H. influenzae, beta-Lac-negative, AMP-resistant or -intermediate strains be confirmed by the MIC procedure.
我们实验室注意到,某些流感嗜血杆菌菌株在巧克力-穆勒-辛顿琼脂(CMH)上对氨苄西林(AMP)纸片的抑菌圈大小被判定为对AMP耐药,但未显示出β-内酰胺酶(β-Lac)活性的证据。虽然已知存在第二种AMP耐药机制,但具有这种机制的菌株并不常见。为了研究这一明显的差异,我们对6个月内收集的100株连续临床分离的流感嗜血杆菌进行了一项研究。采用纸片扩散法和美国国家临床实验室标准委员会(NCCLS)标准,在CMH以及两种品牌的嗜血杆菌检测培养基(HTM)上,同时对分离株进行了针对五种抗生素(AMP、氯霉素、头孢噻肟、环丙沙星和AMP-舒巴坦)的检测。按照CMH和NCCLS标准M2-A3-S2,流感嗜血杆菌菌株对AMP的抑菌圈大小大于或等于20 mm被视为敏感。按照HTM和NCCLS标准M2-A4,在HTM上对AMP的抑菌圈大小大于或等于25 mm的菌株被视为敏感。中介菌株的抑菌圈大小为22至24 mm。大多数分离株(68%)对所有抗生素敏感。2%的分离株对氯霉素耐药。17%的分离株是对AMP耐药、产β-Lac的流感嗜血杆菌菌株。13%的分离株对AMP至少有一个中介或耐药抑菌圈,但β-Lac阴性。对耐药和中介菌株按照NCCLS标准M7-A2进行了最低抑菌浓度(MIC)测定。产β-Lac的流感嗜血杆菌菌株的MIC≥8.0微克/毫升。β-Lac阴性菌株的MIC≤1.0微克/毫升,且具有高度可重复性。如果使用当前的NCCLS抑菌圈直径解释标准,结果应谨慎看待。有必要进一步研究抑菌圈大小解释标准。建议在流感嗜血杆菌严重感染的情况下,通过MIC程序确认β-Lac阴性、对AMP耐药或中介的菌株。